{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T23:17:36Z","timestamp":1782861456153,"version":"3.54.5"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ijbiomac.2025.148337","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T07:11:33Z","timestamp":1760512293000},"page":"148337","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"P1","title":["Cat Eye Syndrome Chromosome Region Candidate 2 (CECR2) in chromatin remodeling and cancer: A review"],"prefix":"10.1016","volume":"331","author":[{"given":"Mahvish","family":"Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Rafiq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabia","family":"Rakhshan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mushtaq A.","family":"Beigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ijbiomac.2025.148337_bb0005","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nrd4286","article-title":"Targeting bromodomains: epigenetic readers of lysine acetylation","volume":"13","author":"Filippakopoulos","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2025.148337_bb0010","series-title":"The CECR2 bromodomain displays distinct binding modes to select for acetylated histone proteins versus non-histone ligands","author":"Phillips","year":"2024"},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.148337_bb0015","doi-asserted-by":"crossref","first-page":"5391","DOI":"10.1021\/acs.jmedchem.6b00264","article-title":"Diving into the water: inducible binding conformations for BRD4, TAF1 (2), BRD9, and CECR2 bromodomains","volume":"59","author":"Crawford","year":"2016","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.148337_bb0020","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1139\/bcb-2021-0019","article-title":"Chromatin remodeling factor CECR2 forms tissue-specific complexes with CCAR2 and LUZP1","volume":"99","author":"Niri","year":"2021","journal-title":"Biochem. Cell Biol."},{"issue":"630","key":"10.1016\/j.ijbiomac.2025.148337_bb0025","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abf5473","article-title":"CECR2 drives breast cancer metastasis by promoting NF-\u03baB signaling and macrophage-mediated immune suppression","volume":"14","author":"Zhang","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ijbiomac.2025.148337_bb0030","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1007\/s12094-021-02603-y","article-title":"A novel tumor suppressor CECR2 down regulation links glutamine metabolism contributes tumor growth in laryngeal squamous cell carcinoma","volume":"23","author":"Wang","year":"2021","journal-title":"Clin. Transl. Oncol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.148337_bb0035","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1021\/acsmedchemlett.7b00132","article-title":"GNE-886: a potent and selective inhibitor of the cat eye syndrome chromosome region candidate 2 bromodomain (CECR2)","volume":"8","author":"Crawford","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ijbiomac.2025.148337_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122568","article-title":"Optical controlled and nuclear targeted CECR2 competitor to downregulate CSF-1 for metastatic breast cancer immunotherapy","volume":"308","author":"Cen","year":"2024","journal-title":"Biomaterials"},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.148337_bb0045","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/10640","article-title":"The bromodomain: a chromatin-targeting module?","volume":"6","author":"Winston","year":"1999","journal-title":"Nat. Struct. Biol."},{"issue":"13","key":"10.1016\/j.ijbiomac.2025.148337_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22136922","article-title":"Molecular complexes at euchromatin, heterochromatin and centromeric chromatin","volume":"22","author":"Morrison","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.148337_bb0055","first-page":"1087","article-title":"ATP-dependent nucleosome remodeling complexes: enzymes tailored to deal with chromatin","volume":"91","author":"Sif","year":"2004"},{"key":"10.1016\/j.ijbiomac.2025.148337_bb0060","series-title":"The Snf2h and Snf2l Nucleosome Remodeling Proteins Co- Modulate Gene Expression and Chromatin Organization to Control Brain Development, Neural Circuitry Assembly and Cognitive Functions","author":"Alvarez-Saavedra","year":"2013"},{"issue":"19","key":"10.1016\/j.ijbiomac.2025.148337_bb0065","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.1111\/j.1742-4658.2011.08282.x","article-title":"Chromatin remodelling in mammalian cells by ISWI-type complexes\u2013where, when and why?","volume":"278","author":"Erdel","year":"2011","journal-title":"FEBS J."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.148337_bb0070","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0968-0004(97)01042-6","article-title":"The bromodomain revisited","volume":"22","author":"Jeanmougin","year":"1997","journal-title":"Trends Biochem. Sci."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2025.148337_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-1119(01)00519-4","article-title":"Structure and function of bromodomains in chromatin-regulating complexes","volume":"272","author":"Marmorstein","year":"2001","journal-title":"Gene"},{"key":"10.1016\/j.ijbiomac.2025.148337_bb0080","series-title":"Bromodomain Biology and Drug Discovery","first-page":"870","volume":"26(10)","author":"Zaware","year":"2019"},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.148337_bb0085","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/j.celrep.2018.10.003","article-title":"Brd4\u2019s bromodomains mediate histone H3 acetylation and chromatin remodeling in pluripotent cells through P300 and Brg1","volume":"25","author":"Wu","year":"2018","journal-title":"Cell Rep."},{"issue":"7327","key":"10.1016\/j.ijbiomac.2025.148337_bb0090","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nature09504","article-title":"Selective inhibition of BET bromodomains","volume":"468","author":"Filippakopoulos","year":"2010","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.148337_bb0095","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1021\/ml5002932","article-title":"1, 3-dimethyl benzimidazolones are potent, selective inhibitors of the BRPF1 bromodomain","volume":"5","author":"Demont","year":"2014","journal-title":"ACS Med. Chem. Lett."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148337_bb0100","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1021\/acs.jmedchem.5b01514","article-title":"Disrupting acetyl-lysine recognition: progress in the development of bromodomain inhibitors","volume":"59","author":"Romero","year":"2016","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.148337_bb0105","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.chembiol.2015.05.009","article-title":"Hijacking the E3 ubiquitin ligase cereblon to efficiently target BRD4","volume":"22","author":"Lu","year":"2015","journal-title":"Chem. Biol."},{"issue":"21","key":"10.1016\/j.ijbiomac.2025.148337_bb0110","doi-asserted-by":"crossref","first-page":"5738","DOI":"10.1002\/anie.201611281","article-title":"Degradation of the BAF complex factor BRD9 by heterobifunctional ligands","volume":"56","author":"Remillard","year":"2017","journal-title":"Angew. Chem. Int. Ed."},{"issue":"19","key":"10.1016\/j.ijbiomac.2025.148337_bb0115","doi-asserted-by":"crossref","first-page":"8111","DOI":"10.1021\/jm5010539","article-title":"The discovery of I-BET726 (GSK1324726A), a potent tetrahydroquinoline ApoA1 up-regulator and selective BET bromodomain inhibitor","volume":"57","author":"Gosmini","year":"2014","journal-title":"J. Med. Chem."},{"issue":"49","key":"10.1016\/j.ijbiomac.2025.148337_bb0120","doi-asserted-by":"crossref","first-page":"19754","DOI":"10.1073\/pnas.1310658110","article-title":"RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain","volume":"110","author":"Picaud","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.148337_bb0125","doi-asserted-by":"crossref","first-page":"4462","DOI":"10.1021\/acs.jmedchem.5b01865","article-title":"Structure-based design of an in vivo active selective BRD9 inhibitor","volume":"59","author":"Martin","year":"2016","journal-title":"J. Med. Chem."},{"issue":"38","key":"10.1016\/j.ijbiomac.2025.148337_bb0130","first-page":"11554","article-title":"A chemical probe for the ATAD2 bromodomain","volume":"128","author":"Bamborough","year":"2016"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148337_bb0135","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/hmg\/ddi048","article-title":"CECR2, a protein involved in neurulation, forms a novel chromatin remodeling complex with SNF2L","volume":"14","author":"Banting","year":"2005","journal-title":"Hum. Mol. Genet."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.148337_bb0140","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/j.str.2015.08.004","article-title":"A subset of human bromodomains recognizes butyryllysine and crotonyllysine histone peptide modifications","volume":"23","author":"Flynn","year":"2015","journal-title":"Structure"},{"issue":"20","key":"10.1016\/j.ijbiomac.2025.148337_bb0145","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1021\/acs.biochem.0c00159","article-title":"NMR analyses of acetylated H2A. Z isoforms identify differential binding interactions with the bromodomain of the NURF nucleosome remodeling complex","volume":"59","author":"Olson","year":"2020","journal-title":"Biochemistry"},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.148337_bb0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003047","article-title":"A combination of H2A. Z and H4 acetylation recruits Brd2 to chromatin during transcriptional activation","volume":"8","author":"Draker","year":"2012","journal-title":"PLoS Genet."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.148337_bb0155","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/0092-8674(95)90217-1","article-title":"ISWI, a member of the SWl2\/SNF2 ATPase family, encodes the 140 kDa subunit of the nucleosome remodeling factor","volume":"83","author":"Tsukiyama","year":"1995","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.148337_bb0160","doi-asserted-by":"crossref","first-page":"4645","DOI":"10.1074\/jbc.M109.072348","article-title":"Chromatin remodeling by imitation switch (ISWI) class ATP-dependent remodelers is stimulated by histone variant H2A. Z","volume":"285","author":"Goldman","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148337_bb0165","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0014-5793(01)03309-9","article-title":"Bromodomain: an acetyl-lysine binding domain","volume":"513","author":"Zeng","year":"2002","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ijbiomac.2025.148337_bb0170","series-title":"Binding of Acf1 to DNA involves a WAC motif and is important for ACF-mediated chromatin assembly","author":"Fyodorov","year":"2002"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148337_bb0175","first-page":"663","volume":"126","author":"Takahashi","year":"2006","journal-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors"},{"issue":"5858","key":"10.1016\/j.ijbiomac.2025.148337_bb0180","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1126\/science.1151526","article-title":"Induced pluripotent stem cell lines derived from human somatic cells","volume":"318","author":"Yu","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2025.148337_bb0185","series-title":"The nuclear factor CECR2 promotes somatic cell reprogramming by reorganizing the chromatin structure","volume":"296","author":"Wu","year":"2021"},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.148337_bb0190","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/carcin\/bgx036","article-title":"Developmental SALL2 transcription factor: a new player in cancer","volume":"38","author":"Hermosilla","year":"2017","journal-title":"Carcinogenesis"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148337_bb0195","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.bbrc.2008.08.170","article-title":"Luzp deficiency affects neural tube closure during brain development","volume":"376","author":"Hsu","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.148337_bb0200","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1290\/1543-706X(2002)38<582:NCIMAT>2.0.CO;2","article-title":"Novel complex integrating mitochondria and the microtubular cytoskeleton with chromosome remodeling and tumor suppressor RASSF1 deduced by in silico homology analysis, interaction cloning in yeast, and colocalization in cultured cells","volume":"38","author":"Liu","year":"2002","journal-title":"In Vitro Cell. Dev. Biol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148337_bb0205","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1042\/BJ20130306","article-title":"Mitochondrion-associated protein LRPPRC suppresses the initiation of basal levels of autophagy via enhancing Bcl-2 stability","volume":"454","author":"Zou","year":"2013","journal-title":"Biochem. J."},{"key":"10.1016\/j.ijbiomac.2025.148337_bb0210","series-title":"The Ras-association domain family (RASSF) members and their role in human tumourigenesis","first-page":"58","volume":"1776(1)","author":"van der Weyden","year":"2007"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148337_bb0215","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1158\/0008-5472.CAN-06-3604","article-title":"Depletion of the Ras association domain family 1, isoform A\u2013associated novel microtubule-associated protein, C19ORF5\/MAP1S, causes mitotic abnormalities","volume":"67","author":"Dallol","year":"2007","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148337_bb0220","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1006\/geno.2001.6679","article-title":"Sequence analysis of LRPPRC and its SEC1 domain interaction partners suggests roles in cytoskeletal organization, vesicular trafficking, nucleocytosolic shuttling, and chromosome activity","volume":"79","author":"Liu","year":"2002","journal-title":"Genomics"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148337_bb0225","doi-asserted-by":"crossref","DOI":"10.1186\/s12887-024-05136-9","article-title":"Clinical and molecular cytogenetic findings of cat eye syndrome and a 2- year-old patient with congenital aural atresia and hearing loss","volume":"24","author":"Xu","year":"2024","journal-title":"BMC Pediatr."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148337_bb0230","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/ddrr.3","article-title":"Molecular mechanisms and diagnosis of chromosome 22q11. 2 rearrangements","volume":"14","author":"Emanuel","year":"2008","journal-title":"Dev. Disabil. Res. Rev."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2025.148337_bb0235","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000079572","article-title":"Small supernumerary marker chromosomes (sSMC) in humans","volume":"107","author":"Liehr","year":"2004","journal-title":"Cytogenet. Genome Res."},{"key":"10.1016\/j.ijbiomac.2025.148337_bb0240","series-title":"Phenotypic variability of Cat-eye syndrome","first-page":"23","volume":"12(1)","author":"Berends","year":"2001"},{"key":"10.1016\/j.ijbiomac.2025.148337_bb0245","series-title":"Hemifacial microsomia in cat-eye syndrome: 22q11. 1\u2013q11. 21 as candidate loci for facial symmetry","first-page":"1985","volume":"161(8)","author":"Quintero-Rivera","year":"2013"},{"key":"10.1016\/j.ijbiomac.2025.148337_bb0250","series-title":"Phenotypic variability of the cat eye syndrome. Case report and review of the literature","first-page":"273","volume":"12(3)","author":"Rosias","year":"2001"},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.148337_bb0255","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1177\/10556656231174435","article-title":"Overlapping spectrum of craniofacial microsomia phenotype in Cat-eye syndrome","volume":"61","author":"Spineli-Silva","year":"2024","journal-title":"Cleft Palate Craniofac. J."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148337_bb0260","doi-asserted-by":"crossref","DOI":"10.1002\/ajmg.a.63476","article-title":"Cat eye syndrome: clinical, cytogenetics and familial findings in a large cohort of 43 patients highlighting the importance of congenital heart disease and inherited cases","volume":"194","author":"Jedraszak","year":"2024","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ijbiomac.2025.148337_bb0265","series-title":"A de novo atypical ring sSMC (22) characterized by array CGH in a boy with cat-eye syndrome","first-page":"1","volume":"7","author":"Haltrich","year":"2014"},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.148337_bb0270","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/ejhg.2012.43","article-title":"A 600 kb triplication in the cat eye syndrome critical region causes anorectal, renal and preauricular anomalies in a three-generation family","volume":"20","author":"Knijnenburg","year":"2012","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.ijbiomac.2025.148337_bb0275","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.798607","article-title":"Whole exome sequencing in 16p13. 11 microdeletion patients reveals new variants through deductive and systems medicine approaches","volume":"13","author":"Granata","year":"2022","journal-title":"Front. Genet."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148337_bb0280","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/dvdy.22547","article-title":"Role of chromatin remodeling gene Cecr2 in neurulation and inner ear development","volume":"240","author":"Dawe","year":"2011","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.ijbiomac.2025.148337_bb0285","first-page":"645335","article-title":"TET enzymes and 5- hydroxymethylcytosine in neural progenitor cell biology and neurodevelopment","volume":"9","author":"MacArthur","year":"2021"},{"key":"10.1016\/j.ijbiomac.2025.148337_bb0290","series-title":"Subfertility in Male and Female Mice with Mutations in Cecr2","author":"Norton","year":"2020"},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.148337_bb0295","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1139\/G07-050","article-title":"Mutation analysis of Drosophila dikar\/CG32394, homologue of the chromatin-remodelling gene CECR2","volume":"50","author":"Keuling","year":"2007","journal-title":"Genome"},{"key":"10.1016\/j.ijbiomac.2025.148337_bb0300","series-title":"Role of Cecr2 and Candidate Modifier Genes of Cecr2 in the Neural Tube Defect Exencephaly","author":"Leduc","year":"2015"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148337_bb0305","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1152\/physiolgenomics.00062.2007","article-title":"Modifier locus for exencephaly in Cecr2 mutant mice is syntenic to the 10q25. 3 region associated with neural tube defects in humans","volume":"31","author":"Davidson","year":"2007","journal-title":"Physiol. Genomics"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.148337_bb0310","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1242\/dmm.024109","article-title":"A mutation in the tuft mouse disrupts TET1 activity and alters the expression of genes that are crucial for neural tube closure","volume":"9","author":"Fong","year":"2016","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.ijbiomac.2025.148337_bb0315","series-title":"Elevated H3K79 homocysteinylation causes abnormal gene expression during neural development and subsequent neural tube defects","first-page":"3436","volume":"9(1)","author":"Zhang","year":"2018"},{"key":"10.1016\/j.ijbiomac.2025.148337_bb0320","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10059-012-0112-4","article-title":"Genome-wide screen of human bromodomain-containing proteins identifies Cecr2 as a novel DNA damage response protein","volume":"34","author":"Lee","year":"2012","journal-title":"Mol. Cells"},{"key":"10.1016\/j.ijbiomac.2025.148337_bb0325","series-title":"Structure and acetyl-lysine recognition of the bromodomain","first-page":"5521","volume":"26(37)","author":"Mujtaba","year":"2007"},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.148337_bb0330","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1021\/bi0611208","article-title":"Solution structure of human Brg1 bromodomain and its specific binding to acetylated histone tails","volume":"46","author":"Shen","year":"2007","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148337_bb0335","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s13058-024-01910-w","article-title":"PTPN20 promotes metastasis through activating NF-\u03baB signaling in triple-negative breast cancer","volume":"26","author":"Zuo","year":"2024","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.ijbiomac.2025.148337_bb0340","series-title":"A single-cell atlas of the tumor and immune ecosystem of human breast cancer","first-page":"1330","volume":"177(5)","author":"Wagner","year":"2019"},{"key":"10.1016\/j.ijbiomac.2025.148337_bb0345","series-title":"Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma","first-page":"4625","volume":"56(20)","author":"Leek","year":"1996"},{"issue":"7355","key":"10.1016\/j.ijbiomac.2025.148337_bb0350","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature10138","article-title":"CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis","volume":"475","author":"Qian","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2025.148337_bb0355","series-title":"From Krebs to clinic: glutamine metabolism to cancer therapy","first-page":"619","volume":"16(10)","author":"Altman","year":"2016"},{"key":"10.1016\/j.ijbiomac.2025.148337_bb0360","series-title":"Glutamine anabolism plays a critical role in pancreatic cancer by coupling carbon and nitrogen metabolism","first-page":"1287","volume":"29(5)","author":"Bott","year":"2019"},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.148337_bb0365","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1172\/JCI69600","article-title":"Glutamine and cancer: cell biology, physiology, and clinical opportunities","volume":"123","author":"Hensley","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"20","key":"10.1016\/j.ijbiomac.2025.148337_bb0370","doi-asserted-by":"crossref","first-page":"7986","DOI":"10.1158\/0008-5472.CAN-09-2266","article-title":"Glioblastoma cells require glutamate dehydrogenase to survive impairments of glucose metabolism or Akt signaling","volume":"69","author":"Yang","year":"2009","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148337_bb0375","doi-asserted-by":"crossref","first-page":"16330","DOI":"10.1038\/s41598-020-73500-7","article-title":"Cytotoxic activity of bromodomain inhibitor NVS-CECR2\u20131 on human cancer cells","volume":"10","author":"Park","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2025.148337_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105768","article-title":"Discovery of a highly potent CECR2 bromodomain inhibitor with 7H- pyrrolo [2, 3-d] pyrimidine scaffold","volume":"123","author":"Lu","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ijbiomac.2025.148337_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106453","article-title":"Discovery of new small molecule inhibitors of the BPTF bromodomain","volume":"134","author":"Liang","year":"2023","journal-title":"Bioorg. Chem."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148337_bb0390","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/cmdc.201800738","article-title":"Advancements in the development of non-BET bromodomain chemical probes","volume":"14","author":"Clegg","year":"2019","journal-title":"ChemMedChem"},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.148337_bb0395","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1021\/acschembio.2c00902","article-title":"Design of class I\/IV bromodomain-targeting degraders for chromatin remodeling complexes","volume":"18","author":"Zahid","year":"2023","journal-title":"ACS Chem. Biol."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025088944?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025088944?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T15:39:51Z","timestamp":1763566791000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025088944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":79,"alternative-id":["S0141813025088944"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.148337","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cat Eye Syndrome Chromosome Region Candidate 2 (CECR2) in chromatin remodeling and cancer: A review","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.148337","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"148337"}}